Electrophysiological studies on oxindole, a neurodepressant tryptophan metabolite

British Journal of Pharmacology

Volumn 125, Issue 8, 1998, Pages 1751-1760

  Mannaioni, Guido ^a   Carpenedo, Raffaella ^a   Pugliese, Anna Maria ^a   Corradetti, Renato ^a   Moroni, Flavio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

CA1; Hippocampus; Na+ channels; Oxindole; Synaptic potentials; Tryptophan metabolism

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; N METHYL DEXTRO ASPARTIC ACID; OXINDOLE; TRYPTOPHAN DERIVATIVE; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DENDRITE; DEPOLARIZATION; DOSE RESPONSE; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; LATENT PERIOD; MALE; MEMBRANE STEADY POTENTIAL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SPIKE;

ACTION POTENTIALS; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; INDOLES; MALE; MICE; MOTOR ACTIVITY; PYRAMIDAL CELLS; RATS; RATS, WISTAR; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION; TRYPTOPHAN;

EID: 0032406147     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702241     Document Type: Article

References (37)

1. ALLEGRI FILIPPINI, G., COSTA, C.V.L. & BERTAZZO, A. (1997). Recent Advances in Tryptophan Research: Tryptophan and Serotonin Pathways. New York: Plenum Publishing Corporation.
2. + channel alpha subunit with novel gating properties. Neuron, 1, 449-461.
3. BASILE, A.S., PANELL, L., JAOUNI, T., GAMMAL, S.H., FALES, H., JONES, E.A. & SKOLNICK, P. (1990). Brain concentration of benzodiazepines are elevated in an animal model of hepatic encephalopathy. Proc. Natl. Acad. Sci. U.S.A., 97, 5263-5267.
4. BENGTSSON, F. & BERGQVIST, P.B.F. (1996). Neuropsychiatric implications of brain tryptophan: Perturbations appearing in hepatic encephalopathy. In Recent Advances in Tryptophan Research, eds. Filippini, G.A. Costa, C.V.L. & Bertazzo, A. pp. 387-395. New York: Plenum Publ. Co.
5. BENGTSSON, F., BUGGE, M., JOHANSEN, K.H. & BUTTERWORTH, R.F. (1991). Brain tryptophan hydroxylation in the portocaval shunted rat: a hypothesis for the regulation of serotonin turnover in vivo. J. Neurochem., 56, 1069-1074.
6. BURTON, N.R., SMITH, D.A.S. & STONE, T.W. (1988). A quantitative pharmacological analysis of some excitatory amino acid receptors in the mouse neocortex 'in vitro'. Br. J. Pharmacol., 93, 693-701.
7. CARLA', V. & MORONI, F. (1992). General anaesthetics inhibit the responses induced by glutamate receptor agonists in the mouse cortex. Nerosci. Lett., 146, 21-24.
8. CARPENEDO, R., CARLA', V., MONETI, G., CHIARUGU, A. & MORONI, F. (1997). Identification and measurement of oxindole (2-indolinone) in the mammalian brain and other rat organs. Analytic. Biochem., 244, 74-79.
9. CARPENEDO, R., CHIARUGI, A., RUSSI, P., LOMBARDI, G., CARLA', V., PELLICCIARI, R., MATTOLI, L. & MORONI, F. (1994). Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenic acid and have sedative and anticonvulsant activities. Neurosci, 61, 237-244.
10. CARPENEDO, R., MANNAIONI, G. & MORONI, F. (1998). Oxindole, a sedative tryptophan metabolite, accumulates in blood and brain of rats with hepatic failure. J. Neurochem., 70, 1998-2003.
11. CATTERALL, W.A. (1981). Localization of sodium channels in cultured neural cells. J. Neurosci., 1, 777-783.
12. CATTERALL, W.A. (1992). Cellular and molecular biology of voltage gated sodium channels. Physiol. Rev., 72, S15-S48.
13. CHIARUGI, A., CARPENEDO R., MOLINA, M.T., MATTOLI, L. PELLICCIARI, R. & MORONI, F. (1995). Comparison of the neurochemical and behavioural effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase. J. Neurochem., 65, 1176-1183.
14. COLLINGRIDGE, G.L., KEHL, S.J. & MCLENNAN, H. (1983). Excitatory amino acids in synaptic transmission in the Schaffer collateral commissural pathway of the rat hippocampus. J. Physiol., 334, 33-46.
15. CORRADETTI, R., LO CONTE, G., MORONI, F., PASSANI, M.B. & PEPEU, G. (1984a). Adenosine modulates aspartate and glutamate release from rat hippocampal slices. Eur. J. Pharmacol., 103, 177-181.
16. CORRADETTI, R., LO CONTE, G., MORONI, F., PASSANI, M.B. & PEPEU, G. (1984b). Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur. J. Pharmacol., 104, 19-26.
17. HARRISON, N.L. & SIMMONDS, M.A. (1985). Quantitative studies of some antagonists of NMDA in slices of rat cerebral cortex. Br. J. Pharmacol., 84, 381-391.
18. HU, G.Y., HVALBY, O., LACAILLE, J.C., PIERCEY, B., OSTBERG, T. & ANDERSEN, P. (1992). Synaptically triggered action potentials begin as a depolarizing ramp in rat hippocampal neurones in vitro. J. Physiol., 453, 663-687.
19. KOCHEN, W., BUHNER, R. & OTTING, W. (1972). Identifizierung von oxindol und 3-indolcarbaldehyd im urim von patienten mit unbehandelter phenylketonurie. Hoppe-Seyler's Z. Physiol. Chem., 353, 1017-1022.
20. KRAFTE, D.S., GOLDIN, A.L., AULD, V.J., DUNN, R.J., DAVIDSON, N. & LESTER, H.A. (1990). Inactivation of cloned Na channel expressed in Xenopus oocytes. J. Gen. Physiol., 96, 689-706.
21. I.I, X.G., SOMOGYI, P., TEPPER, J.M. & BUZSAKI, G. (1992). Axonal and dendritic arborization of an intracellularly labeled chandelier cell in the CA1 region of rat hippocampus. Exp. Brain Res., 90, 519-525.
22. LYNCH, G. & SCHUBERT, P. (1980). The use of in vitro brain slices for multidisciplinary studies of synaptic function. Annu. Rev. Neurosci., 3, 1-22.
23. MACDONALD, R.L., MCLEAN, M.J. & SKERRITT, J.H. (1985). Anticonvulsant drug mechanisms of action. Fed. Proc., 44, 2634-2639.
24. MANNAIONI, G., ALESIANI, M., CARLA', V., NATALINI, B., MARINOZZI, M., PELLICCIARI, R. & MORONI, F. (1994). Sulfate esters of hydroxy amino acids as stereospecific glutamate receptor agonists. Eur. J. Pharmacol., 51, 201-207.
25. MANNAIONI, G., CARLA', V. & MORONI, F. (1996). Pharmacological characterization of metabotropic glutamate receptors potentiating NMDA responses in mouse cortical wedge preparations. Br. J. Pharmacol., 118, 1530-1536.
26. MESSNER, D.J., FELLER, D.J., SCHEUER, T. & CATTERALL, W.A. (1986). Functional properties of rat brain sodium channels lacking the beta 1 or beta 2 subunit. J. Biol. Chem. 261, 14882-14890.
27. MORONI, F., CARPENEDO, R., MANNAIONI, G., GALLI, A., CHIARUGI, A., CARLA', V. & MONETI, G. (1997). Studies on the pharmacological properties of oxindole and 5-hydroxyindole: are they involved in hepatic hencephalopathy? In Advances in cirrhosis, hyperammonemia and hepatic encephalopathy, eds. Felipo, O.V. & Grisolla, S. pp. 57-75. New York: Plenum Press.
28. MORONI, F., CARPENDERO, R., VENTURINI, I., BARALDI, M., ZENEROLI, M.L. (1998). Oxindole in pathogenesis of hepatic encephalopathy. Lancet, 351, 9119.
29. MORONI, F., GALLI, A., MANNAIONI, G., CARLA', V., COZZI, A., MORI, F., MARINOZZI, M. & PELLICCIARI, R. (1995). NMDA receptor heterogeneity in mammalian tissues: focus on two agonists (2S,3R,4S) cyclopropylglutamate and the sulfate ester of 4-hydroxy-(S)-pipecolic acid. Naunyn-Schmied, Arch. Pharmacol., 351, 371-376.
30. OLASMAA, M., GUIDOTTI, A., COSTA, E., ROTHSTEIN, J.D., GOLDMAN, M.E., WEBER, R.J. & PAUL, S.M. (1989). Endogenous benzodiazepines in hepatic encephalopathy. Lancet, 1, 491-492.
31. ORCUTT, J.A., PRYTHERCH, J.P., KONICOV, M. & MICHAELSON, S.M. (1964). Some new compounds exhibiting selective CNS-depressant activities. Part 1. Preliminary observations. Arch. Int. Pharmacodyn., 152, 121-131.
32. PUGLIESE, A.M., BALLERINI, L., PASSANI, M.B. & CORRADETTI, R. (1994). EPSP-spike potentiation during primed burst-induced long-term potentiation in the CA1 region of rat hippocampal slices. Neuroscience, 62, 1021-1032.
33. PUGLIESE, A.M., PASSANI, M.B., PEPEU, G.C. & CORRADETTI, R. (1996). Felbamate decreases synaptic transmission in the CA1 region of rat hippocampal slices. J. Pharmacol. Exp. Ther., 279, 1100-1108.
34. RUDY, B. (1988). Diversity and ubiquity of K channels. Neuroscience, 3, 729-749.
35. STONE, T.W. (1993). Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev., 45, 309-379.
36. STORM, J.F. (1990). Potassium currents in hippocampal pyramidal cells. Prog. Brain Res., 83, 161-187.
37. TRIMMER, J.S., COOPERMAN, S.S., TOMIKO, S.A., ZHOU, J.Y., CREAN, S.M., BOYLE, M.B., KALLEN, R.G., SHENG, Z.H., BARCHI, R.L., SIGWORTH, F.J., GOODMAN, R.H., AGNEW, W.S. & MANDEL, G. (1989). Primary structure and functional expression of a mammalian skeletal muscle sodium channel, Neuron. 3, 33-49.